Merrimack Pharmaceuticals Inc (MACK) Cancer Drugs Sold To Ipsen
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) has resolved to dispose of its cancer drugs unit to Ipsen. Some of these drugs include Doxil and Onivyde.......(read more)
Posts Tagged ‘Merrimack Pharmaceuticals Inc (MACK)’
5 Stocks Hedge Funds Hate The Most
Insider Monkey keeps a keen eye on the activity of the top hedge funds in the world, as our research has shown that hedge funds’ long positions can......(read more)
Merrimack Pharmaceuticals Inc (MACK) Sees Earnings Boost As FDA Accepts Application For Generic Drug
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) and Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) have moved closer to introducing their generic version......(read more)
Here’s Why TASER International, Heron Therapeutics and Three Other Stocks Are Trading Lower on Monday
The markets have opened the fourth quarter on a negative note. While there are uncertainties on account of upcoming presidential election and deteriorating......(read more)
What Is Going On With These Falling Stocks?
After opening flat and falling into the red, the broader markets are now in the green this afternoon as investors weigh the overall positive start to......(read more)
Hedge Funds Have This To Say About Tuesday’s Healthcare Flops
Tuesday was a bad day for three healthcare stocks in particular. Shares of Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Inovio Pharmaceuticals Inc (NASDAQ......(read more)
Should You Buy Merrimack Pharmaceuticals Inc (MACK) After The 10% Surge?
Should you buy Merrimack Pharmaceuticals Inc (NASDAQ:MACK) stock today? The firm’s share price surged 10.22% on June 18 to attain a closing price of......(read more)
Two Directors at Merrimack Pharmaceuticals Inc (MACK) Acquired Almost Half a Million in Stock
June 23, two Board Directors at Merrimack Pharmaceuticals Inc (NASDAQ:MACK), a $741 million market cap biotechnology company, spent a total of $467,787......(read more)
Should You Buy Optimer Pharmaceuticals, Inc. (OPTR)?
Should Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) investors track the following data? At the moment, there are plenty of metrics investors can use to......(read more)
Hedge Funds Are Dumping EXACT Sciences Corporation (EXAS)
Is it smart to be bullish on EXACT Sciences Corporation (NASDAQ:EXAS)? In the financial world, there are a multitude of gauges shareholders can use to......(read more)
Hedge Funds Are Buying ACADIA Pharmaceuticals Inc. (ACAD)
Is it smart to be bullish on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)? In the eyes of many of your fellow readers, hedge funds are viewed as overrated......(read more)
Do Hedge Funds and Insiders Love Halozyme Therapeutics, Inc. (HALO)?
Is Halozyme Therapeutics, Inc. (NASDAQ:HALO) a good investment? Now, according to many investors, hedge funds are seen as delayed, outdated financial......(read more)
Array Biopharma Inc (ARRY): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
Is Array Biopharma Inc (NASDAQ:ARRY) a good investment? At the moment, there are many methods investors can use to analyze Mr. Market. Some of the most......(read more)
Merrimack Pharmaceuticals Inc (MACK), MannKind Corporation (MNKD), Synta Pharmaceuticals Corp. (SNTA): Horrendous Health-Care Stocks This Week
While the major indexes pulled back this week, their declines paled in comparison to the huge drops experienced by a handful of health-care stocks. Here......(read more)
Dendreon Corporation (DNDN), Merrimack Pharmaceuticals Inc (MACK), Novavax, Inc. (NVAX): Three Horrendous Health-Care Stocks This Week
August might be hot for most of the country, but the first full week of the month wasn’t so hot for some stocks. Here are some of the most horrendous......(read more)
GTx, Inc. (GTXI), Intuitive Surgical, Inc. (ISRG): Three Horrendous Health-Care Stocks This Week
A great week for the overall market didn’t trickle down to every stock. Here are three of the most horrendous health-care stocks this week. Not......(read more)
Is Merrimack Pharmaceuticals Inc (MACK) Going to Burn These Hedge Funds?
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) has seen a decrease in hedge fund interest of late. According to most shareholders, hedge funds are seen as......(read more)
Hedge Funds Are Dumping Optimer Pharmaceuticals, Inc. (OPTR)
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) was in 11 hedge funds’ portfolio at the end of March. OPTR investors should be aware of a decrease in......(read more)
Here is What Hedge Funds Think About ACADIA Pharmaceuticals Inc. (ACAD)
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) investors should be aware of a decrease in enthusiasm from smart money lately. To most market participants,......(read more)
Should You Avoid Merrimack Pharmaceuticals Inc (MACK)?
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) shareholders have witnessed a decrease in activity from the world’s largest hedge funds lately. To the......(read more)
Merrimack Pharmaceuticals Inc (MACK) May Be Right For Your Portfolio
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) may be the perfect biotech company for your speculative portfolio. The company had its Initial Public Offering......(read more)
3 Events Biotech Investors Need to Watch in 2013: Vical Incorporated (VICL) and More
It’s make-or-break time in 2013. That’s the situation for several biotech companies with critical phase 3 trials under way. Good results from......(read more)
